A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)	Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic hepatitis B virus infection, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease	Recruiting	Phase 2	2026-09-22		NCT05769816

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chongqing Three Gorges Central Hospital	5
First Affiliated Hospital of Chongqing Medical University	101
Guizhou Provincial People's Hospital	26
The Affiliated Hospital Of Southwest Medical University	17
The Second Affiliated Hospital of Chongqing Medical University	45

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The 2nd affiliated Hospital of Chongqing Medical University	Chongqing	China	5